Mabhuku eFDA & Gwaro reVashandisi

Mabhuku ekushandisa, nhungamiro dzekugadzirisa, rubatsiro rwekugadzirisa matambudziko, uye ruzivo rwekugadzirisa zvigadzirwa zveFDA.

Zano: isa nhamba yakazara yemhando yakadhindwa pane yako FDA label kuti uwane mhando yakakodzera.

Mabhuku ekushandisa eFDA

Zvinyorwa zvitsva, mabhuku ekushandisa akakurumbira, uye mabhuku ekushandisa akabatana nevatengesi vemhando iyi tag.

FDA Zyprexa Olanzapine Tablet Mirayiridzo

FDA Zyprexa Olanzapine Tablet Mirayiridzo

Chikunguru 6, 2024
FDA Zyprexa Olanzapine Tablet Product Information Specifications: Product Name: ZYPREXA Generic Name: Olanzapine Form: Tablet, Nomuromo Disintegrating Product Usage Mirayiridzo: Usati watanga ZYPREXA, verenga Mishonga Guide yakapiwa nemishonga uye zvakare.view nguva imwe neimwe yaunozowanazve.…
Mutengo: FDA
FDA COVID-19 Flu Antigen Self Test Instruction Manual

FDA COVID-19 Flu Antigen Self Test Instruction Manual

Chikunguru 1, 2024
FDA COVID-19 Flu Antigen Self Test Specifications: Product Name: QuickFinderTM COVID-19/Flu Antigen Self Test Intended Use: Qualitative detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B protein antigens Age Requirement: Individuals aged 14 years or older for self-collected specimens,…
Mutengo: FDA
FDA Birth Control Chart Mirayiridzo

FDA Birth Control Chart Mirayiridzo

Chikumi 28, 2024
FDA Kudzora Kuberekwa Chati Chigadzirwa Ruzivo Ruzivo rweChigadzirwa Zita: Kudzora Kuberekwa Gwairira (Chati) Website: www.fda.gov/birthcontrol Purpose: Provides high-level information about different birth control options for educational purposes Disclaimer: Not a complete list of all available birth control options; consult healthcare…
Mutengo: FDA
FDA AD-0401-Bands Science Disclosure Analyst Mirayiridzo

FDA AD-0401-Bands Science Disclosure Analyst Mirayiridzo

Chivabvu 20, 2024
Title 21 Vacancy Announcement Department of Health and Human Services (HHS) Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Office of Communications Outreach and Development (OCOD) Division of Disclosure and Oversight Management (DDOM) AD-0401-Bands Science Disclosure…
Mutengo: FDA
FDA NDA 215487 Naloxone Hydrochloride Nasal Spray User Guide

FDA NDA 215487 Naloxone Hydrochloride Nasal Spray User Guide

Chivabvu 6, 2024
FDA NDA 215487 Naloxone Hydrochloride Nasal Spray Product Information Specifications Product Name: Rezenopy (naloxone hydrochloride) nasal spray, 10 mg Manufacturer: Summit Biosciences Inc. Indication: Emergency treatment of known or suspected opioid overdose Age Group: Adults and pediatric patients Route of…
Mutengo: FDA
FDA SMG 1111.5122 Food And Drug Administration Stock Staff User Guide

FDA SMG 1111.5122 Food And Drug Administration Stock Staff User Guide

Kurume 25, 2024
FDA SMG 1111.5122 Kutarisirwa Kwezvekudya Nemishonga Stock Staff Ruzivo rweChigadzirwa Tsanangudzo Model: SMG 1111.5122 Mugadziri: Dhipatimendi reHutano neHuman Services Zuva rekubvumidzwa: Chikunguru 22, 2021 Zuva reKutanga Kushanda: Nyamavhuvhu 24, 2021 Mirayiridzo yeKushandiswa kweChigadzirwa Kuburitsa uye Kugadzirisa Paunenge…
Mutengo: FDA